• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 门诊患者的嗅觉和味觉障碍:一项前瞻性队列研究。

Olfactory and gustatory dysfunctions in COVID-19 outpatients: A prospective cohort study.

机构信息

Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France; Paris Brain Institute (Inserm, CNRS, Sorbonne Université), Paris, France.

Department of Infectious Diseases, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.

出版信息

Infect Dis Now. 2021 Aug;51(5):440-444. doi: 10.1016/j.idnow.2021.03.004. Epub 2021 Mar 22.

DOI:10.1016/j.idnow.2021.03.004
PMID:33766735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7983360/
Abstract

OBJECTIVES

To describe the characteristics, evolution and risk factors for long-term persistence of olfactory and gustatory dysfunctions (OGD) in COVID-19 outpatients.

PATIENTS AND METHODS

We conducted a prospective study in SARS-CoV-2 infected outpatients with OGD. Weekly phone interviews were set up starting from COVID-19 onset symptoms and over the course of 60 days, using standardized questionnaires that included a detailed description of general symptoms and OGD. The primary outcome was the proportion of patients with complete recovery of OGD at D30. Rate and time to recovery of OGD, as well as risk factors for late recovery (>30 days), were evaluated using Cox regression models.

RESULTS

Ninety-eight outpatients were included. The median time to onset of OGD after first COVID-19 symptoms was 2 days (IQR 0-4). The 30-day recovery rate from OGD was 67.5% (95% CI 57.1-75.4) and the estimated median time of OGD recovery was 20 days (95% CI 13-26). Risk factors for late recovery of OGD were a complete loss of smell or taste at diagnosis (HR=0.26, 95% CI 0.12-0.56, P=0.0005) and age over 40 years (HR=0.56, 95% CI 0.36-0.89, P=0.01).

CONCLUSIONS

COVID-19 patients with complete loss of smell or taste and over age 40 are more likely to develop persistent OGD and should rapidly receive sensorial rehabilitation.

摘要

目的

描述 COVID-19 门诊患者嗅觉和味觉障碍(OGD)长期持续存在的特征、演变和危险因素。

患者和方法

我们对 SARS-CoV-2 感染的 OGD 门诊患者进行了一项前瞻性研究。从 COVID-19 发病症状开始,每周通过电话进行访谈,并持续 60 天,使用标准化问卷,包括一般症状和 OGD 的详细描述。主要结局是 D30 时 OGD 完全恢复的患者比例。使用 Cox 回归模型评估 OGD 恢复的速度和时间,以及(>30 天)延迟恢复的危险因素。

结果

共纳入 98 例门诊患者。从首次 COVID-19 症状出现到 OGD 发病的中位时间为 2 天(IQR 0-4)。30 天 OGD 恢复率为 67.5%(95%CI 57.1-75.4),OGD 恢复的估计中位时间为 20 天(95%CI 13-26)。OGD 延迟恢复的危险因素是诊断时完全丧失嗅觉或味觉(HR=0.26,95%CI 0.12-0.56,P=0.0005)和年龄>40 岁(HR=0.56,95%CI 0.36-0.89,P=0.01)。

结论

完全丧失嗅觉或味觉且年龄>40 岁的 COVID-19 患者更有可能发生持续性 OGD,应尽快进行感觉康复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3608/7983360/891227457e9e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3608/7983360/891227457e9e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3608/7983360/891227457e9e/gr1_lrg.jpg

相似文献

1
Olfactory and gustatory dysfunctions in COVID-19 outpatients: A prospective cohort study.COVID-19 门诊患者的嗅觉和味觉障碍:一项前瞻性队列研究。
Infect Dis Now. 2021 Aug;51(5):440-444. doi: 10.1016/j.idnow.2021.03.004. Epub 2021 Mar 22.
2
[Incidence and prognosis of olfactory and gustatory dysfunctions related to infection of SARS-CoV-2 Omicron strain: a national multi-center survey of 35 566 population].[新型冠状病毒奥密克戎毒株感染相关嗅觉和味觉功能障碍的发病率及预后:一项针对35566人的全国多中心调查]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Jun 7;58(6):579-588. doi: 10.3760/cma.j.cn115330-20230316-00117.
3
Smell and taste loss in COVID-19 patients: assessment outcomes in a Victorian population.新冠病毒患者的嗅觉和味觉丧失:维多利亚州人群的评估结果。
Acta Otolaryngol. 2021 Mar;141(3):299-302. doi: 10.1080/00016489.2020.1855366. Epub 2020 Dec 12.
4
Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study.新冠病毒感染患者嗅觉和味觉障碍的流行率和恢复情况:一项前瞻性多中心研究。
Am J Rhinol Allergy. 2020 Sep;34(5):686-693. doi: 10.1177/1945892420930954. Epub 2020 Jun 12.
5
Olfactory and gustatory dysfunctions in COVID-19 patients: A systematic review and meta-analysis.COVID-19 患者的嗅觉和味觉障碍:系统评价和荟萃分析。
Asian Pac J Allergy Immunol. 2020 Sep;38(3):162-169. doi: 10.12932/AP-210520-0853.
6
Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life.100例因新冠肺炎住院患者的嗅觉和味觉功能障碍:现实生活中的性别差异和恢复时间
Eur Arch Otorhinolaryngol. 2020 Dec;277(12):3519-3523. doi: 10.1007/s00405-020-06102-8. Epub 2020 Jun 4.
7
Chemosensory dysfunction in COVID-19 out-patients.COVID-19 门诊患者的嗅觉味觉障碍。
Eur Arch Otorhinolaryngol. 2021 Mar;278(3):695-702. doi: 10.1007/s00405-020-06266-3. Epub 2020 Aug 25.
8
Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy.意大利奥密克戎 BA.1 波新冠病毒感染后嗅觉和味觉功能障碍的恢复。
Am J Otolaryngol. 2023 Sep-Oct;44(5):103944. doi: 10.1016/j.amjoto.2023.103944. Epub 2023 Jun 8.
9
Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results.COVID-19 门诊患者的主观和心理物理学嗅觉及味觉障碍;短期和长期结果。
PLoS One. 2022 Oct 3;17(10):e0275518. doi: 10.1371/journal.pone.0275518. eCollection 2022.
10
Patterns and clinical outcomes of olfactory and gustatory disorders in six months: Prospective study of 1031 COVID-19 patients.COVID-19 患者嗅觉和味觉障碍的 6 个月模式和临床结局:1031 例前瞻性研究。
Am J Otolaryngol. 2022 Jan-Feb;43(1):103259. doi: 10.1016/j.amjoto.2021.103259. Epub 2021 Sep 30.

引用本文的文献

1
Characteristics of Oral Adverse Effects following COVID-19 Vaccination and Similarities with Oral Symptoms in COVID-19 Patients: Taste and Saliva Secretory Disorders.新型冠状病毒肺炎疫苗接种后口腔不良反应的特征以及与新型冠状病毒肺炎患者口腔症状的相似性:味觉和唾液分泌障碍
Med Princ Pract. 2025;34(2):101-120. doi: 10.1159/000543182. Epub 2024 Dec 19.
2
Neurological Complications of COVID-19 Infection: A Comprehensive Review.新型冠状病毒肺炎感染的神经系统并发症:全面综述
Cureus. 2024 Jul 23;16(7):e65192. doi: 10.7759/cureus.65192. eCollection 2024 Jul.
3
Olfactory dysfunction among patients with COVID-19.

本文引用的文献

1
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.SARS-CoV-2 与 ACE2 受体结合的分子相互作用和抑制。
Nat Commun. 2020 Sep 11;11(1):4541. doi: 10.1038/s41467-020-18319-6.
2
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection.新冠病毒感染导致的嗅觉丧失:潜在机制及经嗅觉途径感染大脑的评估
Neuroscientist. 2021 Dec;27(6):582-603. doi: 10.1177/1073858420956905. Epub 2020 Sep 11.
3
COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction.
新冠患者嗅觉功能障碍。
Saudi Med J. 2023 Nov;44(11):1085-1103. doi: 10.15537/smj.2023.44.11.20230264.
4
Perspective: COVID-19 and Its Neurologic Sequelae.视角:2019冠状病毒病及其神经后遗症
Transl Perioper Pain Med. 2022;9(3):478-481. doi: 10.31480/2330-4871/162.
5
Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves.新冠病毒感染者嗅觉和味觉功能障碍的预后和持续性:使用参数治愈模型对恢复曲线进行荟萃分析。
BMJ. 2022 Jul 27;378:e069503. doi: 10.1136/bmj-2021-069503.
6
Symptoms and signs of long COVID: A rapid review and meta-analysis.长新冠症状和体征:快速综述和荟萃分析。
J Glob Health. 2022 May 21;12:05014. doi: 10.7189/jogh.12.05014.
7
Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up.长新冠症状:在六个月的随访中非重症门诊患者的临床特征和恢复率。
Infect Dis Now. 2022 May;52(3):165-169. doi: 10.1016/j.idnow.2022.02.005. Epub 2022 Feb 11.
8
Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.轻度 COVID-19 门诊患者 429 例的前瞻性研究:症状持续存在的流行率及相关因素。
Infect Dis Now. 2022 Mar;52(2):75-81. doi: 10.1016/j.idnow.2021.11.003. Epub 2021 Nov 17.
9
Neurological sequelae of COVID-19: a review.新型冠状病毒肺炎的神经后遗症:综述
Egypt J Neurol Psychiatr Neurosurg. 2021;57(1):122. doi: 10.1186/s41983-021-00379-0. Epub 2021 Sep 8.
COVID-19 病毒载量与嗅觉和味觉功能障碍严重程度及恢复的关系。
Laryngoscope. 2020 Nov;130(11):2680-2685. doi: 10.1002/lary.29056. Epub 2020 Sep 8.
4
Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study.2019冠状病毒病患者的嗅觉和味觉恢复:一项为期60天的客观前瞻性研究。
J Laryngol Otol. 2020 Aug;134(8):703-709. doi: 10.1017/S0022215120001826. Epub 2020 Aug 12.
5
Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis.新型冠状病毒肺炎患者嗅觉和味觉障碍的系统评价和荟萃分析。
Mayo Clin Proc. 2020 Aug;95(8):1621-1631. doi: 10.1016/j.mayocp.2020.05.030. Epub 2020 Jun 6.
6
Persistent Symptoms in Patients After Acute COVID-19.急性 COVID-19 后患者的持续症状。
JAMA. 2020 Aug 11;324(6):603-605. doi: 10.1001/jama.2020.12603.
7
Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations.病毒性嗅觉功能障碍的治疗:基于证据的综述及推荐。
Int Forum Allergy Rhinol. 2020 Sep;10(9):1065-1086. doi: 10.1002/alr.22624. Epub 2020 Jun 25.
8
Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study.新冠病毒感染患者嗅觉和味觉障碍的流行率和恢复情况:一项前瞻性多中心研究。
Am J Rhinol Allergy. 2020 Sep;34(5):686-693. doi: 10.1177/1945892420930954. Epub 2020 Jun 12.
9
Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.了解 SARS-CoV-2 的神经嗜性特征:从 COVID-19 的神经系统表现到潜在的神经嗜性机制。
J Neurol. 2020 Aug;267(8):2179-2184. doi: 10.1007/s00415-020-09929-7. Epub 2020 May 26.
10
Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.目的:对 86 例 COVID-19 患者的嗅觉自我报告丧失病例系列进行客观嗅觉评估。
Head Neck. 2020 Jul;42(7):1583-1590. doi: 10.1002/hed.26279. Epub 2020 May 21.